Epcoritamab Greenlit as R2 Add-On for R/R FL

FDA clears first bispecific antibody for combination use in relapsed or refractory follicular lymphoma.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/epcoritamab-greenlit-r2-add-r-r-fl-2025a1000w7r?src=rss

Author :

Publish date : 2025-11-19 10:10:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Epcoritamab Greenlit as R2 Add-On for R/R FL

Physics of light and magnetism rewritten after almost two centuries

Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk

Related Posts

Can New Drug Herald Shorter TB Treatment?

Ultra-processed food is global health threat, experts warn

NICE Targets Bleeding Risks With Expanded TXA Advice

Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk

Physics of light and magnetism rewritten after almost two centuries

Breast cancer diagnosis and treatment wait ‘traumatic’ for women, GP says

Can New Drug Herald Shorter TB Treatment?

Ultra-processed food is global health threat, experts warn

NICE Targets Bleeding Risks With Expanded TXA Advice

Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk

Epcoritamab Greenlit as R2 Add-On for R/R FL

Physics of light and magnetism rewritten after almost two centuries

Breast cancer diagnosis and treatment wait ‘traumatic’ for women, GP says

Epstein-Barr Virus Alters B Cells, Possibly Driving Lupus

Categories

Archives